Recently, targeted protein degradation approaches have identified the small molecules CC-885 and CC-90009 as eRF3a degraders with potent tumoricidal activity against acute myeloid leukemia (AML) cells (22–27). This evidence concerns the gene GSPT1 and acute myeloid leukemia.